Visualization of Intermetastatic Heterogeneity in Mixed Neuroendocrine Carcinoma-Acinar Adenocarcinoma of the Prostate by 68Ga-PSMA, 68Ga-FAPI, and 18F-FDG PET/CT

被引：4
|
作者：
Cai, Jiayu [1 ,2 ]
Xu, Weizhi [1 ,2 ]
Meng, Tinghua [1 ,2 ]
Pang, YiZhen [1 ,2 ]
Chen, Haojun [1 ,2 ,3 ]
机构：
[1] Xiamen Univ, Affiliated Hosp 1, Xiamen Canc Ctr, Sch Med,Dept Nucl Med, Xiamen, Peoples R China
[2] Xiamen Univ, Affiliated Hosp 1, Minnan PET Ctr, Xiamen Canc Ctr,Sch Med, Xiamen, Peoples R China
[3] 55 Zhenhai Rd, Xiamen 361003, Peoples R China
来源：
CLINICAL NUCLEAR MEDICINE | 2023年 / 48卷 / 08期
基金：
中国国家自然科学基金;
关键词：
F-18-FDG; Ga-68-FAPI; Ga-68-PSMA; neuroendocrine adenocarcinoma; neuroendocrine prostate cancer; PET/CT;
D O I：
10.1097/RLU.0000000000004719
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Mixed neuroendocrine carcinoma-acinar carcinoma is an uncommon histological type of neuroendocrine prostate cancer. It has been rarely reported in de novo prostate malignancies. In this case, we present Ga-68-PSMA (prostate-specific membrane antigen), Ga-68-FAPI, and F-18-FDG PET/CT findings in the de novo form of mixed large-cell neuroendocrine carcinoma-acinar adenocarcinoma of the prostate. Different levels of radiotracer uptake were observed in different metastatic sites on Ga-68-PSMA, Ga-68-FAPI, and F-18-FDG PET/CT. This case demonstrates that the multitracer PET/CT strategy may be used for the noninvasive detection of the intermetastatic heterogeneity in metastatic neuroendocrine prostate cancer.
引用
收藏
页码：743 / 745
页数：3
相关论文
共 50 条
  • [41] 68Ga-FAPI and 18F-PET/CT Images in Intestinal Tuberculosis
    Zheng, Jieling
    Lin, Kaixian
    Zheng, Shan
    Yao, Shaobo
    Miao, Weibing
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (03) : 239 - 240
  • [42] 68Ga-FAPI and 18F-FDG PET/CT Imaging in Langerhans Cell Histiocytosis for Recurrence and Therapeutic Response Assessment
    Liu, Mengna
    Tang, Ranbie
    Chen, Xi
    Cai, Liang
    Huang, Zhanwen
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (11) : 1027 - 1030
  • [43] 68Ga-FAPI and 18F-FDG PET/CT Images of a Patient With Rosai-Dorfman Disease With Liver Involvement
    Chen, Zhenying
    Xue, Qianqian
    Yang, Yun
    Shun, Hu
    Miao, Weibing
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (12) : 1079 - 1081
  • [44] Dermatomyositis on 68Ga-FAPI PET/CT in a Patient With Nasopharyngeal Carcinoma
    Wu, Junhao
    Qiu, Lin
    Wang, Yingwei
    Zhang, Chunyin
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (02) : 149 - 150
  • [45] 68Ga-DOTA-FAPI-04 PET/CT in Neuroendocrine Carcinoma of the Liver With Elevated AFP Level Comparison With 18F-FDG PET/CT
    Ergul, Nurhan
    Yilmaz, Burcak
    Cin, Merve
    Cermik, Tevfik Fikret
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (01) : E29 - E31
  • [46] 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT Findings of Abdominal Leiomyosarcoma
    Guzel, Yunus
    Can, Canan
    Sogutcu, Nilgun
    Gundes, Ebubekir
    Gundogan, Cihan
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (12) : E594 - E597
  • [47] Primary Cardiac Hemangiopericytoma on 18F-FDG and 68Ga-FAPI-04 PET/CT
    Li, Chuan
    Deng, Yichuan
    Hu, Xianwen
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (11) : e598 - e600
  • [48] Early Detection of Gastric Intramucosal Adenocarcinoma on 68Ga-FAPI PET/CT
    Liu, Huipan
    Xiang, Feifan
    Deng, Jia
    Li, Kehong
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (08) : 737 - 739
  • [49] 68Ga-PSMA-HBED-CC PET/CT and 18F-FDG PET/CT in Ewing Sarcoma
    Parihar, Ashwin Singh
    Sood, Apurva
    Mittal, Bhagwant Rai
    Kumar, Rajender
    Singh, Harmandeep
    Dhatt, Sarvdeep Singh
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : E57 - E58
  • [50] Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer
    Wenxiao Yu
    Ming Zhao
    Yingjun Deng
    Shengjing Liu
    Guanchao Du
    Bin Yan
    Ziwei Zhao
    Ning Sun
    Jun Guo
    Cancer Imaging, 23
12345